# Tofacitinib

## Xeljanz 5mg

| TAH Drug Code      | [OXELJ](https://www.tahsda.org.tw/drugs/hissearch.php?drug_code=OXELJ)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
|:-------------------|:-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Indications        | 1. Rheumatoid Arthritis Indicated for the treatment of adult patients with moderate to severe active rheumatoid arthritis (RA) who have had an inadequate response to or are intolerant to methotrexate. 2. Psoriatic Arthritis In combination with non-biologic disease-modifying antirheumatic drugs (DMARDs)， indicated for the treatment of adult patients with active psoriatic arthritis (PsA) who have had an inadequate response to or are intolerant to methotrexate or other disease-modifying antirheumatic drugs (DMARDs). 3. Ankylosing Spondylitis Indicated for the treatment of adult patients with active ankylosing spondylitis (AS) who have had an inadequate response to or are intolerant to nonsteroidal anti-inflammatory drugs (NSAIDs). 4. Ulcerative Colitis Indicated for the treatment of adult patients with moderate to severe active ulcerative colitis who have had an inadequate response to or are intolerant to corticosteroids， azathioprine， 6-mercaptopurine (6-MP)， or TNF inhibitor therapy. 5. Polyarticular Juvenile Idiopathic Arthritis Indicated for the treatment of active polyarticular juvenile idiopathic arthritis (pcJIA) in patients over 2 years old. |
| Dosing             | Rheumatoid arthritis， psoriatic arthritis， ankylosing spondylitis: 5 mg orally twice daily. Ulcerative colitis induction dose 10 mg orally twice daily (8-16 weeks)， maintenance dose 5 mg orally twice daily.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
| Hepatic Impairment | Dose adjustment required                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
| Renal Impairment   | Dose adjustment required                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
| Contraindications  | Hypersensitivity to tofacitinib or any component of the formulation                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |
| Adverse Effects    | Common: Increased HDL level (10-12%)， Low density lipoprotein cholesterol above reference range (15-19%)， Headache (3.4-9%)， Urinary tract infectious disease (2%)， Nasopharyngitis (2.8-14%)， Upper respiratory infection (3.8-6%) Serious: Cardiovascular morbidity， Major adverse cardiac events (MACE)， Death， Cardiovascular， Myocardial infarction， Skin cancer， Non-melanoma， Gastrointestinal perforation， Anemia (2-4%)， Arterial thrombosis， Decreased lymphocyte count (0.04%)， Deep venous thrombosis， Neutropenia (0.07%)， Hepatotoxicity， Infectious disease (20-22%)， Malignant lymphoma， Opportunistic infection， Post-transplant lymphoproliferative disorder， Epstein Barr virus associated (2.3%)， Tuberculosis， Cerebrovascular accident， Lung cancer， Pulmonary embolism， Cancer                                                                                                                                                                                                                                                                                                                                                                                |
| Pregnancy          | No (Limited) Human Data – Animal Data Suggest Low Risk                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
| Lactation          | No (Limited) Human Data - Potential Toxicity                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
| More Info          | [UpToDate](https://www.uptodate.com/contents/tofacitinib-drug-information)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |

